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Abstract
This commentary on a paper by Bendel and colleagues in the
previous issue of Critical Care describes the difficulty in assessing
the sufficiency of adrenal responses to endogenous, stress-
induced adrenocorticotropic hormone (ACTH) release by the
pituitary or to exogenous ACTH administration in the critically ill
patient in general, and after subarachnoid hemorrhage in particular.
It is argued that comparisons with responses under circumstances
of equal stress as well as assessments of severity of disease are
necessary to judge the sufficiency of cortisol responses to endo-
genous and exogenous ACTH before treatment is considered.
There are no universally applicable cutoff values for cortisol levels -
and increases in cortisol levels with increasing levels of ACTH - for
the diagnosis of relative adrenal insufficiency (or as it is now
commonly termed, critical illnes-related corticosteroid insufficiency)
following, for example, subarachnoid hemorrhage or other
intracranial catastrophes. The paper by Bendel and colleagues is
critically discussed in view of these concepts.
The expression ‘enough is enough’ refers to the idea that we
can unambiguously decide on what is sufficient in life. The
question is whether this also applies to medicine and
science, where uncertainties may outweigh certainties. In the
previous issue of Critical Care, the sufficiency of hypo-
thalamo-pituitary-adrenal (HPA) function over time following
subarachnoid hemorrhage (SAH) is addressed [1]. We
interpret the findings by the authors on the basis of increases
in circulating adrenocorticotropic hormone (ACTH), but not of
circulating cortisol, with increasing clinical severity of SAH,
and that some (relative) adrenal insufficiency is present in
severely afflicted patients in the acute phase, compared to
controls, even though the study does not allow one to
determine whether controls (after aneurysm surgery) were
equally stressed. In any case, lower cortisol levels than in
acute SAH patients suggest lower stress levels. A
comparison with the literature is hard, since there are very
few data on acute HPA axis activity after SAH [2].
Indeed, expected responses to stress - caused, for instance,
by intracranial catastrophes such as traumatic brain injury and
SAH - would include increases in endogenous ACTH and,
thereby, in cortisol secretion relative to normal, unstressed
levels, with a concomitant elevation of circulating (total and
free) cortisol levels [2-5]. Sufficient adaptation to the stress
response would be suggested by parallel increases in ACTH
and cortisol levels acording to the degree of stress
associated with the severity of disease (assessed by scoring
systems) [2,6,7]. The ratio between ACTH levels and free
cortisol levels, which is expected to be maintained because
of feedback activity, could provide an index of adrenal
sensitivity to ACTH [5]. Adrenal sensitivity can increase with
prolonged stress-induced ACTH stimulation or release of
stimulating factors other than ACTH, which cause the ratio to
decrease; on the other hand, an increase in the ratio would
denote adrenal insensitivity and thus perhaps insufficiency, as
the paper by Bendel and colleagues [1] seems to suggest.
However, (even free) cortisol levels in serum do not neces-
sarily accurately reflect the rate of adrenal cortisol secretion,
and the additive value of determinations of free cortisol levels
for the interpretation of the sufficiency of response (to
disease severity and/or endogenous ACTH) remains unclear
[3,4], as is the case in the paper by Bendel and colleagues
[1]. When (in)sufficiency of HPA axis activation and ACTH/
cortisol secretion is suspected for a given severity of disease,
additional assessment of responses to stimulation tests for
determining sensitivity may provide further information with
which to judge deviations from non-stressed normality [5].
The response to additional stress can be mimicked by ACTH
stimulation, even though (surgical) stress may increase free
cortisol levels more than a supraphysiological dose of ACTH
[4]. This implies that HPA axis sufficiency can be judged by
assessing the sensitivity of adrenal responses to endogenous
and exogenous ACTH, the levels of which are determined by
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the severity of disease and direct stimulation, respectively,
and which frequently interrelate in a reciprocal manner [5,7].
For instance, high baseline (free) cortisol levels associated
with severe stress may be associated with some decrease in
delta cortisol levels upon ACTH stimulation. Therefore, there
are no fixed and universally applicable cutoff points to
separate insufficient from sufficient adrenal responses in the
critically ill, depending on severity of disease. Hence,
although delta cortisol cutoff values have been found to be
predictive for (survival) benefits of hydrocortisone treatment
in septic shock [7], their use for non-septic patients, including
those with SAH, as was done in the paper by Bendel and
colleagues and other papers [1,8], makes little sense. Even
though similar responses in acute SAH patients and controls
[1] suggest sufficient adrenal responses after SAH, we do
not know whether the responses depended on the clinical
severity of SAH. Otherwise, sliding responses may contribute
to poor acceptance of the ACTH test for adrenocortical
function during critical illness.
The causes and consequences, and thus the clinical signfi-
cance, of the proposed relative adrenal insufficiency after
SAH as suggested by Bendel and colleagues [1] remain
obscure. In any case, patients on etomidate, well known for
its suppressive action on the adrenals, were excluded from
the study by Bendel and colleagues. Corticosteroids given in
the acute phase of SAH do not afford a survival benefit [9],
even though hydrocortisone treatment may attenuate hypo-
natremia, which commonly develops during the course of
disease and therapy with hypervolemia and is often attributed
to cerebral salt waisting [10]. Nevertheless, the clinical
manifestations of relative adrenal insufficiency in the setting
of SAH are largely unknown and require future investigation,
but might include vasopressor-insensitive hypotension and
hyponatremia in the acute phase. However, the study by Bendel
and colleagues [1] does not suggest such associations.
As a late complication in the disease course after SAH and
the resultant damage, secondary HPA axis insufficiency may
supervene when the stress of the acute phase has waned
and ACTH release by the pituitary still seems insufficient
[2,11-14]. In the study by Bendel and colleagues [1], a
follow-up assessment was made at 3 months in SAH
survivors and little evidence for secondary HPA insufficiency
was found, in contrast to previous observations, suggesting
that insufficiency may be transient in the long term [11-14].
Indeed, some authors suggest that weight gain, growth
hormone and gonadal deficiencies in the chronic phase could
be explained by (pan)hypopituitarism [2,11-14]. In contrast,
low (that is, subnormal) ACTH and cortisol levels early in the
course of SAH in the study by Bendel and colleagues [1]
could have been caused by (transient) secondary HPA
insufficiency, as also found by others [2,5].
Taken together, the sufficiency of the HPA stress response to
intracranial catastrophies remains hard to establish, as
exemplified in the paper by Bendel and colleagues [1]. We
propose that for judging adrenal sensitivity, HPA (in)suffi-
ciency should be defined in terms of both clinical and labora-
tory (ab)normalities. The authors of the current paper on SAH
[1] only partly succeed in applying the above concepts and
potential HPA insufficiency after SAH remains open for
further study.
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